In addition, we observed higher infiltration of CD8+ T cells—the primary effector in anti-tumor immunity—in RRAP-mutant tumors compared to RRAP-wild type tumors, although it did not reach a statistical significance (p-value = 0.07385, Figure 5A). Here, CD8A is linked to neoplasm.